London Co Of Virginia Decreased By $3.56 Million Its Bristol Myers Squibb Co (BMY) Position; Varian Medical Systems (VAR) Has 0.95 Sentiment

October 12, 2017 - By Dolores Ford

London Co Of Virginia decreased Bristol Myers Squibb Co (BMY) stake by 5.75% reported in 2017Q2 SEC filing. London Co Of Virginia sold 64,780 shares as Bristol Myers Squibb Co (BMY)’s stock declined 1.04%. The London Co Of Virginia holds 1.06 million shares with $59.13M value, down from 1.13 million last quarter. Bristol Myers Squibb Co now has $106.43 billion valuation. The stock declined 0.06% or $0.04 reaching $65.07 per share. About 1.05 million shares traded. Bristol-Myers Squibb Co (NYSE:BMY) has declined 23.19% since October 12, 2016 and is downtrending. It has underperformed by 39.89% the S&P500.

Varian Medical Systems, Inc. is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy. The company has market cap of $9.28 billion. The Firm also has Varian Particle Therapy and the activities of the Ginzton Technology Center (GTC). It has a 32.6 P/E ratio. The Company’s VPT business develops, designs, makes, sells and services products and systems for delivering proton therapy, another form of external beam radiotherapy using proton beams for the treatment of cancer.

About 50,523 shares traded. Varian Medical Systems, Inc. (VAR) has risen 29.46% since October 12, 2016 and is uptrending. It has outperformed by 12.76% the S&P500.

Ratings analysis reveals 50% of Varian Medical’s analysts are positive. Out of 2 Wall Street analysts rating Varian Medical, 1 give it “Buy”, 0 “Sell” rating, while 1 recommend “Hold”. The lowest target is $93.0 while the high is $98.0. The stock’s average target of $95.50 is -5.86% below today’s ($101.45) share price. VAR was included in 2 notes of analysts from January 23, 2017. The stock of Varian Medical Systems, Inc. (NYSE:VAR) has “Outperform” rating given on Friday, January 27 by Barrington Research. As per Monday, January 23, the company rating was maintained by RBC Capital Markets.

Saratoga Research & Investment Management holds 3.84% of its portfolio in Varian Medical Systems, Inc. for 468,428 shares. Lafleur & Godfrey Llc owns 137,529 shares or 3.73% of their US portfolio. Moreover, Capital Counsel Llc Ny has 3.08% invested in the company for 328,218 shares. The Alberta – Canada-based Qv Investors Inc. has invested 3.02% in the stock. Fairpointe Capital Llc, a Illinois-based fund reported 1.41 million shares.

Since January 1, 0001, it had 0 insider purchases, and 9 selling transactions for $10.10 million activity.

Analysts await Varian Medical Systems, Inc. (NYSE:VAR) to report earnings on October, 25 after the close. They expect $1.19 earnings per share, down 13.77% or $0.19 from last year’s $1.38 per share. VAR’s profit will be $108.85M for 21.31 P/E if the $1.19 EPS becomes a reality. After $1.04 actual earnings per share reported by Varian Medical Systems, Inc. for the previous quarter, Wall Street now forecasts 14.42% EPS growth.

Investors sentiment decreased to 0.95 in 2017 Q2. Its down 0.03, from 0.98 in 2017Q1. It dropped, as 78 investors sold BMY shares while 520 reduced holdings. 120 funds opened positions while 451 raised stakes. 1.10 billion shares or 2.26% less from 1.12 billion shares in 2017Q1 were reported. 24,213 were accumulated by Clark Capital Management Group Inc Incorporated. Murphy Pohlad Asset Mgmt Limited Liability holds 0.67% of its portfolio in Bristol-Myers Squibb Co (NYSE:BMY) for 16,223 shares. Missouri-based Plancorp Limited Liability Co has invested 0.09% in Bristol-Myers Squibb Co (NYSE:BMY). Guardian Invest Mgmt owns 39,115 shares. First Commercial Bank reported 1.59% in Bristol-Myers Squibb Co (NYSE:BMY). Legacy Private Tru invested in 0.13% or 17,878 shares. Northstar Invest Limited Company reported 0.59% of its portfolio in Bristol-Myers Squibb Co (NYSE:BMY). Boothbay Fund Mgmt Limited Liability Company holds 0.05% of its portfolio in Bristol-Myers Squibb Co (NYSE:BMY) for 4,096 shares. Apriem holds 0.07% of its portfolio in Bristol-Myers Squibb Co (NYSE:BMY) for 5,047 shares. Signature Fincl invested in 0.15% or 8,327 shares. Michigan-based Azimuth Ltd Company has invested 0.56% in Bristol-Myers Squibb Co (NYSE:BMY). Moreover, Apg Asset Mngmt Nv has 0.16% invested in Bristol-Myers Squibb Co (NYSE:BMY) for 1.57M shares. National Bank & Trust Of The Ozarks reported 1.25% stake. Nomura Asset Mngmt Limited, a Japan-based fund reported 273,299 shares. Bingham Osborn & Scarborough Llc reported 8,230 shares.

London Co Of Virginia increased Cooper Tire & Rubr Co (NYSE:CTB) stake by 688,093 shares to 1.59M valued at $57.45 million in 2017Q2. It also upped Chevron Corp New (NYSE:CVX) stake by 26,130 shares and now owns 2.27M shares. Dst Sys Inc Del (NYSE:DST) was raised too.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.